These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23118872)

  • 1. Comparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma.
    Shen J; Wang W; Wu J; Feng B; Chen W; Wang M; Tang J; Wang F; Cheng F; Pu L; Tang Q; Wang X; Li X
    PLoS One; 2012; 7(10):e47476. PubMed ID: 23118872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion.
    Tan FL; Ooi A; Huang D; Wong JC; Qian CN; Chao C; Ooi L; Tan YM; Chung A; Cheow PC; Zhang Z; Petillo D; Yang XJ; Teh BT
    Int J Cancer; 2010 May; 126(10):2353-61. PubMed ID: 19816939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues.
    Kawase H; Fujii K; Miyamoto M; Kubota KC; Hirano S; Kondo S; Inagaki F
    J Proteome Res; 2009 Aug; 8(8):4092-103. PubMed ID: 19569727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.
    Hashim Abdalla MS; Taylor-Robinson SD; Sharif AW; Williams HR; Crossey MM; Badra GA; Thillainayagam AV; Bansi DS; Thomas HC; Waked IA; Khan SA
    HPB (Oxford); 2011 Jun; 13(6):385-90. PubMed ID: 21609370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.
    Seol MA; Chu IS; Lee MJ; Yu GR; Cui XD; Cho BH; Ahn EK; Leem SH; Kim IH; Kim DG
    BMC Cancer; 2011 Feb; 11():78. PubMed ID: 21333016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
    Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B
    Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma.
    Matsuda A; Kuno A; Matsuzaki H; Kawamoto T; Shikanai T; Nakanuma Y; Yamamoto M; Ohkohchi N; Ikehara Y; Shoda J; Hirabayashi J; Narimatsu H
    J Proteomics; 2013 Jun; 85():1-11. PubMed ID: 23612463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis.
    Lukic N; Visentin R; Delhaye M; Frossard JL; Lescuyer P; Dumonceau JM; Farina A
    Biochim Biophys Acta; 2014 May; 1844(5):1026-33. PubMed ID: 23872482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.
    Farina A; Dumonceau JM; Antinori P; Annessi-Ramseyer I; Frossard JL; Hochstrasser DF; Delhaye M; Lescuyer P
    Biochim Biophys Acta; 2014 May; 1844(5):1018-25. PubMed ID: 23806607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGR5 promotes cholangiocarcinoma by interacting with mortalin.
    Li AD; Xie XL; Qi W; Wang WB; Ma JJ; Zhao DQ; Jiang XY; Chen L; Bai Y; Jiang HQ
    Exp Cell Res; 2020 Apr; 389(2):111855. PubMed ID: 31978385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma.
    Padden J; Megger DA; Bracht T; Reis H; Ahrens M; Kohl M; Eisenacher M; Schlaak JF; Canbay AE; Weber F; Hoffmann AC; Kuhlmann K; Meyer HE; Baba HA; Sitek B
    Mol Cell Proteomics; 2014 Oct; 13(10):2661-72. PubMed ID: 25034945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy.
    Sharif AW; Williams HR; Lampejo T; Khan SA; Bansi DS; Westaby D; Thillainayagam AV; Thomas HC; Cox IJ; Taylor-Robinson SD
    HPB (Oxford); 2010 Aug; 12(6):396-402. PubMed ID: 20662790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma.
    Meng ZW; Liu MC; Hong HJ; Du Q; Chen YL
    Tumour Biol; 2017 Mar; 39(3):1010428317694319. PubMed ID: 28345461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
    Bernuzzi F; Marabita F; Lleo A; Carbone M; Mirolo M; Marzioni M; Alpini G; Alvaro D; Boberg KM; Locati M; Torzilli G; Rimassa L; Piscaglia F; He XS; Bowlus CL; Yang GX; Gershwin ME; Invernizzi P
    Clin Exp Immunol; 2016 Jul; 185(1):61-71. PubMed ID: 26864161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker.
    Verathamjamras C; Weeraphan C; Chokchaichamnankit D; Watcharatanyatip K; Subhasitanont P; Diskul-Na-Ayudthaya P; Mingkwan K; Luevisadpaibul V; Chutipongtanate S; Champattanachai V; Svasti J; Srisomsap C
    Int J Oncol; 2017 Jul; 51(1):269-280. PubMed ID: 28560424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.